Synteract, Inc.
20
0
0
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 20/100
15.0%
3 terminated/withdrawn out of 20 trials
84.2%
-2.3% vs industry average
35%
7 trials in Phase 3/4
88%
14 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Role: collaborator
Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics
Role: collaborator
Evaluation of the Efficacy and Safety of LevoCept
Role: collaborator
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
Role: collaborator
A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC
Role: collaborator
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Role: collaborator
A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)
Role: collaborator
Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)
Role: collaborator
Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)
Role: collaborator
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Role: collaborator
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Role: collaborator
Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Role: collaborator
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
Role: collaborator
Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
Role: collaborator
A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults
Role: collaborator
Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics
Role: collaborator
Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults
Role: collaborator
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
Role: collaborator
Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows
Role: collaborator
A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows
Role: collaborator
All 20 trials loaded